Search results
Gateway - Quartz
Quartz· 11 hours agoThe company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose. According to The People’s Vaccine Alliance, a ...
Pfizer gene therapy for Duchenne fails to meet goals of key trial
BioPharma Dive via Yahoo Finance· 6 days agoThe negative results from the Phase 3 study, called Ciffreo, come a little more than a month after ...
Pfizer’s Phase III DMD gene therapy trial misses primary endpoint
Clinical Trials Arena via Yahoo Finance· 5 days agoPfizer has reported that its Phase III CIFFREO clinical trial of investigational mini-dystrophin...
Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday? - BioNTech (NASDAQ:BNTX)
Benzinga· 15 hours agoBioNTech SE’s BNTX partner MediLink Therapeutics (Suzhou) Co., Ltd says the FDA has placed a partial clinical hold on the Phase 1 trial. The MediLink-sponsored trial evaluates the early-stage ...
Gateway - Quartz
Quartz· 4 hours agoModerna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of Health-System Pharmacists said the number of ongoing ...
Voisard Asset Management Group Inc. Takes $86,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 3 days agoVoisard Asset Management Group Inc. bought a new stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to the company in its most recent ...
Pfizer’s gene-therapy trial failure boosts Sarepta’s stock
Market Watch· 5 days agogained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a...
Pfizer Inc. (NYSE:PFE) Shares Sold by Cresset Asset Management LLC
ETF DAILY NEWS· 6 days agoCresset Asset Management LLC reduced its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 13.5% in the fourth quarter, according to the company in its most recent disclosure ...
Bridgeway Capital Management LLC Boosts Stock Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 5 days agoBridgeway Capital Management LLC boosted its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 26.0% during the 4th quarter, according to its most recent 13F filing ...
Pfizer faces setback with gene therapy acquired from North Carolina firm - Triangle Business Journal
The Business Journals· 5 days agoPfizer is facing a major clinical setback in a gene therapy program with ties to the Triangle. The...
